CataractSurgery.com, an online resource for patient education, has been launched by Alcon, Inc.

The Premium Experience Network (PEN), a membership programme designed to enhance the professional competitiveness of refractive surgeons? practices, has been launched by Shareef Mahdavi of SM2 Strategic.

Generic versions of dorzolamide-timolol (Cosopt) and dorzolamide hydrochloride (Trusopt; Merck) are now available from Prasco.

Members of the European Ophthalmology forum debate the usefulness of congresses to the ophthalmology community.

The fixed combination of brimonidine/timolol is more cost effective than dorzolamide/timolol, according to a study published in the September/October issue of the European Journal of Ophthalmology.

The intellectual property dispute between Carl Zeiss Meditec and Optovue has been resolved by the companies, ahead of the legal case reaching court.

Alcon is continuing to invest heavily in its future drug portfolio by forging links with GlaxoSmithKline (GSK) for the global ophthalmic rights to cilomilast, a phosphodiesterase IV inhibitor, and by expanding an existing alliance with Origenis GmbH for the discovery and development of small molecules.

An Indian doctor is planning to perform 200 cataract extractions free of cost within 15 hours in November in order to secure a place in the Guinness Book of World Records.

Markus Schill, PhD and Clemens Wagner, PhD of VRMagic GmbH have received the European VitreoRetinal Society's annual Relja Zivojnovic Award for outstanding contributions to the field of vitreoretinal surgery.